Bob Pooler
Bob Pooler is an analyst at Valuation Lab, where he provides insights on pharmaceutical developments. Recently, he has been in the news for his optimistic assessment of Cosmo's potential hair growth medication, Breezula, predicting significant market success and annual revenues of up to 2.5 billion euros if the product secures a strong distribution partner.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Switzerland | 1 | 8.00 | 0.09% | +0% | 8,654,622 | 7,700 | $700,000 | 623$ |
| Totals | 1 | 8,654,622 | 7,700 | $700,000 | 623$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Switzerland:
Bob Pooler is an analyst from Valuation Lab who believes the hair growth medication has good chances for approval.
8